Publications
- Ikaros (IKZF1) alterations and minimal residual disease at day 15 assessed by flow cytometry predict prognosis of childhood BCR/ABL-negative acute lymphoblastic leukemia2013 | Second Faculty of Medicine
- Minimal Residual Disease-Based Risk Stratification in Chinese Childhood Acute Lymphoblastic Leukemia by Flow Cytometry and Plasma DNA Quantitative Polymerase Chain Reaction2013 | Second Faculty of Medicine
- HOX Gene Expression in Phenotypic and Genotypic Subgroups and Low HOXA Gene Expression as an Adverse Prognostic Factor in Pediatric ALL2010 | Faculty of Science, Second Faculty of Medicine
- Third consecutive national study ALL-BFM 95 improved the outcome of acute lymphoblastic leukemia in children in the Czech Republic2008 | Second Faculty of Medicine, First Faculty of Medicine, Faculty of Physical Education and Sport
- Correlation of CD33 with poorer prognosis in childhood ALL implicates a potential of anti-CD33 frontline therapy2005 | Second Faculty of Medicine
- Phenotypic profiling of CD34+ cells by advanced flow cytometry improves diagnosis of Juvenile Myelomonocytic Leukemia2024 | Second Faculty of Medicine
- Minimal residual disease assessment in B-cell precursor acute lymphoblastic leukemia by semi-automated identification of normal hematopoietic cells: A EuroFlow study2024 | Second Faculty of Medicine
- CD371+ pediatric B-cell acute lymphoblastic leukemia: propensity to lineage switch and slow early response to treatment2024 | Second Faculty of Medicine
- The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms (vol 36, pg 1720, 2022)2023 | Second Faculty of Medicine, Faculty of Medicine in Pilsen
- Flow cytometric minimal residual disease assessment in B-cell precursor acute lymphoblastic leukaemia patients treated with CD19-targeted therapies - a EuroFlow study2022 | Second Faculty of Medicine
Loading network view...
